Injection Drug Use and HIV Antiretroviral Therapy Discontinuation in A Canadian Setting

被引:0
|
作者
Dan Werb
M.-J. Milloy
Thomas Kerr
Ruth Zhang
Julio Montaner
Evan Wood
机构
[1] British Columbia Centre for Excellence in HIV/AIDS,Division of AIDS, Department of Medicine
[2] St. Paul’s Hospital,undefined
[3] School of Population and Public Health,undefined
[4] University of British Columbia,undefined
[5] University of British Columbia,undefined
来源
AIDS and Behavior | 2013年 / 17卷
关键词
Antiretroviral therapy; ART; Injection drug use; Retention; Discontinuation; HIV;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated whether drug-related behaviors predicted antiretroviral therapy (ART) discontinuation among a cohort of injection drug users (IDU) in a Canadian setting. Cox regression analyses were used to investigate the impact of drug use patterns on rates of ART discontinuation among a sample of HIV-positive IDU in Vancouver, Canada between May 1996 and April 2008. In total, 408 HIV-positive IDU initiated ART during the study period, among whom 257 (63.0%) discontinued ART at least once. Rates of ART discontinuation were not significantly elevated among those who reported ongoing injection of heroin, cocaine, or other illicit drugs in comparison to those who reported not injecting drugs. However, public drug use was significantly predictive of ART discontinuation. Our findings may contribute to a reconsideration of the role of active drug use in determining retention in ART programs among IDU.
引用
收藏
页码:68 / 73
页数:5
相关论文
共 50 条
  • [31] Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting
    Miller C.L.
    Strathdee S.A.
    Spittal P.M.
    Kerr T.
    Li K.
    Schechter M.T.
    Wood E.
    [J]. Harm Reduction Journal, 3 (1)
  • [32] Adherence and antiretroviral therapy in injection drug users
    Sherer, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06): : 567 - 568
  • [33] Antiretroviral therapy: A key part of the public health response to injection drug use
    Wood, Evan
    Montaner, Julio S. G.
    [J]. ADDICTION, 2008, 103 (04) : 660 - 661
  • [34] Injection drug users report antiretroviral use
    不详
    [J]. AIDS PATIENT CARE AND STDS, 1998, 12 (11) : 871 - 872
  • [35] Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users
    Wood, Evan
    Kerr, Thomas
    Hogg, Robert S.
    Palepu, Anita
    Zhang, Ruth
    Strathdee, Steffanie A.
    Montaner, Julio S. G.
    [J]. DRUG AND ALCOHOL REVIEW, 2006, 25 (05) : 451 - 454
  • [36] Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
    Piggott, Damani A.
    Karakousis, Petros C.
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [37] Discontinuation of antiretroviral therapy in HIV/AIDS patients at the end of life.
    Ruiz, M. A.
    Reske, T.
    Abdo, A.
    Marts, R.
    Hudson, W.
    Heiman, M.
    Aguilar, E.
    Cefalu, C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S173 - S173
  • [38] Drug resistance in antiretroviral therapy of HIV infection
    Oette, M
    Häussinger, D
    [J]. MEDIZINISCHE KLINIK, 2003, 98 (12) : 692 - 699
  • [39] HIV-1 Antiretroviral Drug Therapy
    Arts, Eric J.
    Hazuda, Daria J.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04):
  • [40] Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration
    May, Margaret T.
    Justice, Amy C.
    Birnie, Kate
    Ingle, Suzanne M.
    Smit, Colette
    Smith, Colette
    Neau, Didier
    Guiguet, Marguerite
    Schwarze-Zander, Carolynne
    Moreno, Santiago
    Guest, Jodie L.
    Monforte, Antonella d'Arminio
    Tural, Cristina
    Gill, Michael J.
    Bregenzer, Andrea
    Kirk, Ole
    Saag, Michael
    Sterling, Timothy R.
    Crane, Heidi M.
    Sterne, Jonathan A. C.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (03) : 348 - 354